Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.
Publication
, Journal Article
Jones, DI; McGee, CE; Sample, CJ; Sempowski, GD; Pickup, DJ; Staats, HF
Published in: Clin Vaccine Immunol
July 2016
Modified vaccinia Ankara virus (MVA) is a smallpox vaccine candidate. This study was performed to determine if MVA vaccination provides long-term protection against rabbitpox virus (RPXV) challenge, an animal model of smallpox. Two doses of MVA provided 100% protection against a lethal intranasal RPXV challenge administered 9 months after vaccination.
Duke Scholars
Published In
Clin Vaccine Immunol
DOI
EISSN
1556-679X
Publication Date
July 2016
Volume
23
Issue
7
Start / End Page
648 / 651
Location
United States
Related Subject Headings
- Vaccinia virus
- Survival Analysis
- Smallpox Vaccine
- Smallpox
- Rabbits
- Microbiology
- Immunology
- Immunization Schedule
- Female
- Disease Models, Animal
Citation
APA
Chicago
ICMJE
MLA
NLM
Jones, D. I., McGee, C. E., Sample, C. J., Sempowski, G. D., Pickup, D. J., & Staats, H. F. (2016). Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge. Clin Vaccine Immunol, 23(7), 648–651. https://doi.org/10.1128/CVI.00216-16
Jones, Dorothy I., Charles E. McGee, Christopher J. Sample, Gregory D. Sempowski, David J. Pickup, and Herman F. Staats. “Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.” Clin Vaccine Immunol 23, no. 7 (July 2016): 648–51. https://doi.org/10.1128/CVI.00216-16.
Jones DI, McGee CE, Sample CJ, Sempowski GD, Pickup DJ, Staats HF. Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge. Clin Vaccine Immunol. 2016 Jul;23(7):648–51.
Jones, Dorothy I., et al. “Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.” Clin Vaccine Immunol, vol. 23, no. 7, July 2016, pp. 648–51. Pubmed, doi:10.1128/CVI.00216-16.
Jones DI, McGee CE, Sample CJ, Sempowski GD, Pickup DJ, Staats HF. Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge. Clin Vaccine Immunol. 2016 Jul;23(7):648–651.
Published In
Clin Vaccine Immunol
DOI
EISSN
1556-679X
Publication Date
July 2016
Volume
23
Issue
7
Start / End Page
648 / 651
Location
United States
Related Subject Headings
- Vaccinia virus
- Survival Analysis
- Smallpox Vaccine
- Smallpox
- Rabbits
- Microbiology
- Immunology
- Immunization Schedule
- Female
- Disease Models, Animal